Showing 3161-3170 of 3223 results for "".
- Intraocular Robotic Surgery Feasible: First-in-Human Studyhttps://modernod.com/news/intraocular-robotic-surgery-feasible-first-in-human-study/2480072/For the first time in humans, a remotely controlled electronic robotic device has been used to perform highly precise intraocular surgery, according to a Reuters report. “The robot has the potential to operate with far more pr
- American Academy of Ophthalmology Reiterates Long-Standing Guidance on LASIK Patient Educationhttps://modernod.com/news/american-academy-of-ophthalmology-reiterates-long-standing-guidance-on-lasik-patient-education/2480085/The American Academy of Ophthalmology reiterated its long-standing guidance for patients considering LASIK vision correction surgery. The possible complications from this elective procedure have long been known but have nevertheless garnered recent attention in the national media. &
- Optovue Announces Expanded FDA Clearance of Epithelial Thickness Mappinghttps://modernod.com/news/optovue-announces-expanded-fda-clearance-of-epithelial-thickness-mapping/2480088/Optovue announced an expanded FDA 510(k) clearance for non-contact, quantitative measurements of the epithelial and stromal layers of the cornea, termed epithelial thickness mapping (ETM). The expanded clearance adds a 9-millimeter ETM scan to the previously available 6-millimeter map, allowing f
- Optovue Receives FDA Clearance for AngioAnalytics – the First OCT Angiography Metrics Technologyhttps://modernod.com/news/optovue-receives-fda-clearance-for-angioanalytics-the-first-oct-angiography-metrics-technology/2480103/Optovue announced FDA 510(k) clearance of AngioAnalytics, the first optical coherence tomography angiography (OCTA) blood vessel measurement technology to help clinicians manage diseases that cause progressive blindness. The company also received clearance for its three-dimensional projection art
- FDA Approves First Artificial Irishttps://modernod.com/news/fda-approves-first-artificial-iris/2480126/The FDA approved the first stand-alone prosthetic iris in the United States, a surgically implanted device to treat adults and children whose iris is completely missing or damaged. “Patients with iris defects may experience severe vision problems, as well as dissatisfaction with the appear
- Study Compares the Accuracy of Subjective Refraction Using a Vmax Vision’s VASR vs. Traditional Refractionhttps://modernod.com/news/study-compares-the-accuracy-of-subjective-refraction-using-a-vmax-visions-vasr-vs-traditional-refraction/2480157/A comparison study reported at ARVO 2018, conducted by Drs. Christopher Lievens, Christina Newman, Alan Kabat, and optometry student Jacob Weber at the Southern College of Optometry (SCO), included 50 healthy subjects
- Diopsys: Study Highlights the Important Role of PERG in Evaluation of Manifest and Suspected Glaucomahttps://modernod.com/news/diopsys-study-highlights-the-important-role-of-perg-in-evaluation-of-manifest-and-suspected-glaucoma/2480170/Pattern electroretinography (PERG) is again revealed as a powerful tool for evaluating patients with early stage glaucoma, particularly glaucoma suspects, according to a news release from Diopsys. According to the latest study published in Current Ophthalmology Reports by Porciatt
- Iridex Announces Increase in Micropulse Visibility at ARVOhttps://modernod.com/news/iridex-announces-increase-in-micropulse-visibility-at-arvo/2480183/Iridex has announced that ARVO attendees will have access to over 20 posters presenting data on the use of MicroPulse technology. Eleven studies cover the use of MicroPulse technology for the treatment of glaucoma while the remaining studies present data on the use of MicroPulse for diverse patho
- Hill-Rom Enhances Spot Vision Screener to Serve Senior Populationhttps://modernod.com/news/hill-rom-enhances-spot-vision-screener-to-serve-senior-population/2480205/Hill-Rom announced new enhancements to its Welch Allyn Spot Vision Screener, enabling the device to quickly and effectively screen for vision issues in adult patients with pupil sizes as small as 3 mm, according to a company news release. Spot Vision Screener is a handheld, portable device
- Novartis Launches App to Collect Patient Data in Studies for Ophthalmic Diseaseshttps://modernod.com/news/novartis-launches-app-to-collect-patient-data-in-studies-for-ophthalmic-diseases/2480209/Novartis announced the launch of its FocalView app, an ophthalmic digital research platform that aims to allow researchers to track disease progression by collecting real-time, self-reported data directly from consenting patients. By adapting the design of clinical trials to suit the daily routin